Home › Products › Oncology › Inlyta 5mg Tablet
Inlyta 5mg Tablet
Salt Composition: AXITINIB
- Manufacturer: PFIZER LTD
- Pack Size: 14 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 5MG
- Prescription Required
- Storage: Keep Inlyta 5mg tablets in their original packaging and store them at room temperature, ideally between 20°C and 25°C. Ensure the medication is kept out of the reach of children at all times.
₹31456.00₹39128.44
Inclusive of all taxes
Product Introduction
Inlyta 5mg contains the active ingredient axitinib, a tyrosine kinase inhibitor indicated for advanced renal cell carcinoma. This medication can harm a developing fetus; inform your doctor if you are pregnant or planning to become pregnant. Both men and women should use effective contraception during treatment and for one week after the final dose. Do not breastfeed during treatment, as the drug may affect infant development. Use in children and adolescents under 18 years of age is not recommended. Contact your healthcare provider urgently if you experience arrhythmia, chest pain, or persistent cough. Your doctor may arrange regular monitoring of white blood cell count, platelets, blood glucose, electrolytes, and renal function to prevent complications. Report any gastrointestinal symptoms including diarrhoea, nausea, vomiting, or constipation to your healthcare provider promptly.
Uses
Inlyta 5mg uses are: Targets specific enzymes to prevent the growth and spread of cancer cells. Aids in reducing symptoms associated with advanced kidney cancer, improving the patient's quality of life.
How it works
Axitinib is a tyrosine kinase inhibitor. It disrupts the growth of blood vessels within cancer cells and targets receptor tyrosine kinases, a type of protein crucial for cell signalling. By interfering with these pathways, it effectively halts the proliferation and spread of cancer cells, contributing to the containment of the disease
How to Use
Your doctor will decide the dose and duration of Inylta 5mg tablet based on the disease condition. Always take this medicine as prescribed by your doctor. The recommended starting oral dose is 5 mg twice daily. Take the tablet at the same time every day, with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next Inlyta 5mg tablet dosage at the scheduled time. Do not take a double dose to make up for a forgotten dose.
Side Effects
Inlyta 5mg side effects of the drug range from the most common ones to those you should take a closer look at. Here is what you need to know: Common: Kidney issues and dehydration Sore throat and loss of appetite Joint pain and weight loss Skin reactions, including itching, redness, and hair loss Serious: Severe fatigue and swelling Chest pain or pressure, especially radiating to arms, back, neck, or jaw Shortness of breath and difficulty speaking Significant bleeding, such as black stools or bloody cough
References
- Pfizer Labs, Electronic Medicines Compendium(EMC), [Revised on Mar 2021] [Accessed on 23rd March 2023], https://www.medicines.org.uk/emc/files/pil.4325.pdf
- Pfizer, Fact sheet, [Revised on Sep 2012] [Accessed on 23rd March 2023], https://cdn.pfizer.com/pfizercom/news/esmo/renal_cell_carcinoma_fact_sheet.pdf
- Annex I summary of Product Characteristics - European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/product-information/inlyta-epar-product-information_en.pdf (Accessed on March 25, 2023).
- Edward Chu, Cancer Chemotherapy, Langeâs Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
Safety Advice
Pregnancy: unsafe Inylta 5mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Lungs: Consult your doctor It is not known whether Inylta 5mg tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe It is unsafe to breastfeed during the treatment with Inylta 5mg tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.